Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART

  1. Palacios, R.
  2. Pérez-Hernández, I.A.
  3. Martínez, M.A.
  4. Mayorga, M.L.
  5. González-Domenech, C.M.
  6. Omar, M.
  7. Olalla, J.
  8. Romero, A.
  9. Romero, J.M.
  10. Pérez-Camacho, I.
  11. Hernández-Quero, J.
  12. Santos, J.
Aldizkaria:
European Journal of Clinical Microbiology and Infectious Diseases

ISSN: 1435-4373 0934-9723

Argitalpen urtea: 2016

Alea: 35

Zenbakia: 5

Orrialdeak: 815-819

Mota: Artikulua

DOI: 10.1007/S10096-016-2602-3 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak